Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $838M (100.0% shares, 0.0% debt)

Holdings (33)

— SPRINGWORKS THERAPEUTICS INC 16.5%

Value $138M Shares 4,831,307 Est. Cost $21.68 Unrealized —

NUVL NUVALENT INC 8.0%

Value $66.64M Shares 3,428,014 Est. Cost $29.01 Unrealized -42.3%

— MERSANA THERAPEUTICS INC 7.0%

Value $58.57M Shares 8,663,673 Est. Cost $12.65 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 6.8%

Value $57.33M Shares 3,000,000 Est. Cost $26.87 Unrealized -15.7%

— DYNAVAX TECHNOLOGIES CORP 6.7%

Value $56.53M Shares 5,415,000 Est. Cost $9.83 Unrealized —

— EQRX INC 5.9%

Value $49.52M Shares 10,003,573 Est. Cost $6.82 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 5.4%

Value $45.28M Shares 2,305,558 Est. Cost $18.69 Unrealized +9.1%

— THIRD HARMONIC BIO INC 5.2%

Value $43.25M Shares 2,280,082 Est. Cost $18.97 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 3.4%

Value $28.8M Shares 1,023,214 Est. Cost $22.45 Unrealized +11.1%

RPID RAPID MICRO BIOSYSTEMS INC 3.3%

Value $27.24M Shares 8,434,560 Est. Cost $20.66 Unrealized -81.2%

— CARA THERAPEUTICS INC 3.0%

Value $24.78M Shares 2,647,473 Est. Cost $9.13 Unrealized —

PHVS PHARVARIS N V 2.9%

Value $24.39M Shares 3,180,601 Est. Cost $31.46 Unrealized -50.4%

NRIX NURIX THERAPEUTICS INC 2.8%

Value $23.75M Shares 1,822,883 Est. Cost $21.10 Unrealized -25.0%

ANNX ANNEXON INC 2.7%

Value $22.26M Shares 3,601,926 Est. Cost $21.65 Unrealized -75.0%

— 2SEVENTY BIO INC 2.4%

Value $20.5M Shares 1,408,901 Est. Cost $18.15 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.3%

Value $19.06M Shares 2,260,572 Est. Cost $12.09 Unrealized -21.7%

SVRA SAVARA INC 2.2%

Value $18.02M Shares 11,622,598 Est. Cost $1.49 Unrealized +8.2%

CCCC C4 THERAPEUTICS INC 1.7%

Value $14.4M Shares 1,642,210 Est. Cost $29.00 Unrealized -64.2%

AVIR ATEA PHARMACEUTICALS INC 1.7%

Value $14.14M Shares 2,485,638 Est. Cost $32.23 Unrealized -76.3%

— X4 PHARMACEUTICALS INC 1.3%

Value $10.93M Shares 6,389,436 Est. Cost $4.61 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 1.2%

Value $9.988M Shares 610,523 Est. Cost $18.64 Unrealized -13.1%

— MARINUS PHARMACEUTICALS INC 1.1%

Value $9.517M Shares 1,431,058 Est. Cost $15.48 Unrealized —

XLO XILIO THERAPEUTICS INC 1.0%

Value $8.164M Shares 2,805,413 Est. Cost $17.03 Unrealized -83.7%

SYRS SYROS PHARMACEUTICALS INC 0.8%

Value $6.971M Shares 1,082,404 Est. Cost $8.12 Unrealized 0.0%

TNGX TANGO THERAPEUTICS INC 0.8%

Value $6.957M Shares 1,921,790 Est. Cost $11.99 Unrealized -64.4%

IVVD INVIVYD INC 0.7%

Value $6.063M Shares 1,937,207 Est. Cost $37.11 Unrealized -89.2%

— ARYA SCIENCES ACQUISITN CORP 0.6%

Value $4.905M Shares 500,000 Est. Cost $9.88 Unrealized —

— BCLS ACQUISITION CORP 0.6%

Value $4.885M Shares 487,500 Est. Cost $11.14 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 0.5%

Value $4.24M Shares 2,000,000 Est. Cost $10.83 Unrealized -76.8%

— SOLID BIOSCIENCES INC 0.4%

Value $3.7M Shares 7,929,918 Est. Cost $7.99 Unrealized —

— APTINYX INC 0.4%

Value $3.273M Shares 8,891,758 Est. Cost $8.16 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.4%

Value $3.045M Shares 300,000 Est. Cost $10.38 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.3%

Value $2.813M Shares 5,347,689 Est. Cost $5.13 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$138M	16.5%	$21.68	—	COM	85205L107
NUVL	NUVALENT INC	3,428,014	$66.64M	8.0%	$29.01	-42.3%	COM	670703107
—	MERSANA THERAPEUTICS INC	8,663,673	$58.57M	7.0%	$12.65	—	COM	59045L106
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,000,000	$57.33M	6.8%	$26.87	-15.7%	COM	03969K108
—	DYNAVAX TECHNOLOGIES CORP	5,415,000	$56.53M	6.7%	$9.83	—	COM NEW	268158201
—	EQRX INC	10,003,573	$49.52M	5.9%	$6.82	—	COM	26886C107
CRNX	CRINETICS PHARMACEUTICALS IN	2,305,558	$45.28M	5.4%	$18.69	+9.1%	COM	22663K107
—	THIRD HARMONIC BIO INC	2,280,082	$43.25M	5.2%	$18.97	—	COM	88427A107
AMLX	AMYLYX PHARMACEUTICALS INC	1,023,214	$28.8M	3.4%	$22.45	+11.1%	COM	03237H101
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$27.24M	3.3%	$20.66	-81.2%	CLASS A COM	75340L104
—	CARA THERAPEUTICS INC	2,647,473	$24.78M	3.0%	$9.13	—	COM	140755109
PHVS	PHARVARIS N V	3,180,601	$24.39M	2.9%	$31.46	-50.4%	COM	N69605108
NRIX	NURIX THERAPEUTICS INC	1,822,883	$23.75M	2.8%	$21.10	-25.0%	COM	67080M103
ANNX	ANNEXON INC	3,601,926	$22.26M	2.7%	$21.65	-75.0%	COM	03589W102
—	2SEVENTY BIO INC	1,408,901	$20.5M	2.4%	$18.15	—	COMMON STOCK	901384107
PTGX	PROTAGONIST THERAPEUTICS INC	2,260,572	$19.06M	2.3%	$12.09	-21.7%	COM	74366E102
SVRA	SAVARA INC	11,622,598	$18.02M	2.2%	$1.49	+8.2%	COM	805111101
CCCC	C4 THERAPEUTICS INC	1,642,210	$14.4M	1.7%	$29.00	-64.2%	COM STK	12529R107
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$14.14M	1.7%	$32.23	-76.3%	COM	04683R106
—	X4 PHARMACEUTICALS INC	6,389,436	$10.93M	1.3%	$4.61	—	COM	98420X103
ACAD	ACADIA PHARMACEUTICALS INC	610,523	$9.988M	1.2%	$18.64	-13.1%	COM	004225108
—	MARINUS PHARMACEUTICALS INC	1,431,058	$9.517M	1.1%	$15.48	—	COM NEW	56854Q200
XLO	XILIO THERAPEUTICS INC	2,805,413	$8.164M	1.0%	$17.03	-83.7%	COM	98422T100
SYRS	SYROS PHARMACEUTICALS INC	1,082,404	$6.971M	0.8%	$8.12	0.0%	COM NEW	87184Q206
TNGX	TANGO THERAPEUTICS INC	1,921,790	$6.957M	0.8%	$11.99	-64.4%	COM	87583X109
IVVD	INVIVYD INC	1,937,207	$6.063M	0.7%	$37.11	-89.2%	COM	00534A102
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4.905M	0.6%	$9.88	—	CLASS A ORD SHS	G31658100
—	BCLS ACQUISITION CORP	487,500	$4.885M	0.6%	$11.14	—	COM CL A	G0904B105
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$4.24M	0.5%	$10.83	-76.8%	COM	63909J108
—	SOLID BIOSCIENCES INC	7,929,918	$3.7M	0.4%	$7.99	—	COM	83422E105
—	APTINYX INC	8,891,758	$3.273M	0.4%	$8.16	—	COM	03836N103
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$3.045M	0.4%	$10.38	—	UNIT 12/09/2025	G3710A121
—	AEGLEA BIOTHERAPEUTICS INC	5,347,689	$2.813M	0.3%	$5.13	—	COM	00773J103